H.R. 1613 – Drug Price Transparency in Medicaid Act
Congress Takes Action to Address Anticompetitive PBM Practices in the Medicaid Program
WASHINGTON, DC – On Friday, United States Representatives Buddy Carter (R-GA), Vicente Gonzalez D-TX), Elise Stefanik (R-NY), Deborah Ross (D-NC), Rick Allen (R-GA), and Jake Auchinclossto (D-MA) introduced bipartisan legislation to address certain anticompetitive market practices that impact specialty pharmacies. The Drug Price Transparency in Medicaid Act of 2023 would eliminate the practice of spread pricing in state Medicaid programs, no longer intentionally reducing pharmacy reimbursement through this practice. Please click here to read the full Press Release.